Clinical efficacy of demineralized dentin matrix particles in immediate implantation for bone defects in posterior region: a 1 to 5-year follow-up study.
10.7518/hxkq.2025.2024419
- Author:
Hao WU
1
;
Ning CAO
1
;
Liangwei CAO
1
;
Fei YU
1
;
Xu ZHANG
1
;
Shibo WEI
1
;
Hongwu WEI
1
;
Shuigen GUO
1
Author Information
1. Dept. of Stomatology, The Fourth Affiliated Hospital of Nanchang University, Nanchang 330009, China.
- Publication Type:Journal Article
- Keywords:
bone defect;
demineralized dentin matrix particles;
immediate implantation;
simple taper retention
- MeSH:
Humans;
Follow-Up Studies;
Dentin;
Cone-Beam Computed Tomography;
Dental Implants;
Male;
Female;
Adult;
Alveolar Bone Loss/surgery*;
Middle Aged;
Bone Transplantation;
Radiography, Panoramic;
Dental Implantation, Endosseous/methods*;
Immediate Dental Implant Loading
- From:
West China Journal of Stomatology
2025;43(4):570-583
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVES:This study aims to evaluate the short- to medium-term clinical efficacy of demineralized dentin matrix (DDM) particles applied during the immediate implantation of alveolar bone defects in the posterior region.
METHODS:A total of 76 patients with 110 simple taper retentive implants were included in the conducted study and divided into Groups A and B in accordance with the bone grafting materials. Cone beam computed tomography and panoramic radiographs were taken immediately after implant surgery, immediate crown repair, and final follow-up time. The average follow-up time for Groups A and B was recorded. The primary observed clinical indicators were overall survival rate of the implant, bone resorption of the mesial and distal margins of the implant, buccal bone width resorption at the platform level and 1 mm below the platform, and bone height of the implant. Implant complication was a secondary observed clinical indicator.
RESULTS:During the 1-to-5-year follow-up observation period, the mean follow-up of Group A was 38.2 months while that of Group B was 39.9 months. In Group A, two implants failed, one of which fractured, and implant overall survival rate was 96.4%. Four implants failed in Group B due to peri-implantitis, and implant overall survival rate was 92.6%. No statistically significant difference in implant overall survival rate was found between the two groups (P>0.05). In Group A, the average bone resorption in the mesial and distal margins of the implants was (1.011±2.047) mm and (0.841±2.183) mm, respectively. In Group B, the average bone resorption of the mesial and distal margins of the implants was (1.546±1.778) mm and (1.431±1.909) mm, respectively. No statistically significant difference was noted between the two groups (P>0.05). In Group A, buccal bone width resorption at the platform level and 1 mm below the platform of the implant was (0.782±2.084) mm and (0.681±2.307) mm, respectively. In Group B, buccal bone width resorption at the platform level and 1 mm below the platform of implant was (1.071±1.474) mm and (0.949±1.909) mm, respectively. No statistically significant difference was found between the two groups (P>0.05). In Group A, the buccal bone height of resorption of the implant was (1.044±2.214) mm. In Group B, the buccal bone height of resorption of the implant was (1.075±1.456) mm. No statistically significant difference in bone height was observed between the two groups (P>0.05).
CONCLUSIONS:During the 1-to-5-year follow-up observation period, DDM particles can effectively increase the height and width of alveolar bone, and they can achieve the same effect of maintaining alveolar bone contour and bone augmentation compared with deproteinized inorganic calf bone. DDM particles can be used as a potential new bone grafting material for the treatment of bone defects in clinical practice.
